| 10.1093/rheumatology/keaf341 |
40.811.657 |
Mekinian, A ; Meneses, S ; Biard, L ; Dagna, L ; Novikov, P ; Salvarani, C & al |
Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: multicenter retrospective study. |
Rheumatology (Oxford) |
2025 |
|
|
| 10.1097/MEJ.0000000000001264 |
40.772.434 |
Ricard-Hibon, A ; Brenckmann, V ; Gorlicki, J ; Soulat, L ; Bagou, G ; Pradeau, C & al |
Effect of the score predicting imminent delivery on the management of unexpected out-of-hospital obstetrical deliveries: a cluster randomized clinical trial. |
Eur J Emerg Med |
2025 |
|
|
| 10.1016/S2213-2600(25)00125-0 |
40.652.952 |
Lemiale, V ; Resche-Rigon, M ; Zerbib, Y ; Mokart, D ; De Prost, N ; Wallet, F & al |
Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial. |
Lancet Respir Med |
2025 |
|
|
| 10.4088/JCP.25m15826 |
40.608.475 |
Geoffroy, PA ; Chevret, S ; Mauries, S ; Chaffaut, C ; Amad, A ; Bellivier, F & al |
Bright Light Therapy in the Morning or Midday for the Treatment of Nonseasonal Depression in Bipolar Disorder (LuBi): A Dose-Escalation Phase 1/2 Randomized Double-Blind Trial. |
J Clin Psychiatry |
2025 |
86 |
|
| 10.1007/s00134-025-07945-7 |
40.512.201 |
Bouchereau, E ; Pruvost-Robieux, E ; Siami, S ; Chaffaut, C ; Bouglé, A ; Gavaret, M & al |
Altered lower brainstem neurophysiological response is associated with mortality in deeply sedated critically ill patients. |
Intensive Care Med |
2025 |
51 |
1050-1061 |
| 10.1016/j.ophtha.2025.05.026 |
40.484.138 |
Jacquot, R ; Sève, P ; Mulier, G ; Hankard, A ; Maalouf, G ; Kodjikian, L & al |
Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis Uveitis. |
Ophthalmology |
2025 |
|
|
| 10.1056/NEJMoa2505133 |
40.459.097 |
Perrot, A ; Lambert, J ; Hulin, C ; Pieragostini, A ; Karlin, L ; Arnulf, B & al |
Measurable Residual Disease-Guided Therapy in Newly Diagnosed Myeloma. |
N Engl J Med |
2025 |
393 |
425-437 |
| 10.1186/s40164-025-00661-4 |
40.380.332 |
Kapandji, N ; Salmona, M ; Lemoine, A ; Ulmann, G ; Calderaro, J ; Roche, B & al |
Unravelling neutropenic enterocolitis: insights from gut microbiota, and intestinal barrier analyses. |
Exp Hematol Oncol |
2025 |
14 |
74 |
| 10.1164/rccm.202408-1669OC |
40.315.144 |
Hajage, D ; Gaudry, S ; Combes, A ; Lemiale, V ; Schmidt, M ; Lambert, J |
Improving the Reporting of Trials Evaluating Organ Support Therapies Using Multistate Modeling. |
Am J Respir Crit Care Med |
2025 |
211 |
1418-1426 |
| 10.1016/j.cct.2025.107906 |
40.233.850 |
Couturier, R ; Chevret, S ; Lambert, J |
Evaluation of the survival-inferred fragility index to assess the robustness of the estimated treatment effect on survival endpoints. |
Contemp Clin Trials |
2025 |
153 |
107906 |
| 10.1016/j.diii.2025.03.007 |
40.180.796 |
Selvam, S ; Peyrony, O ; Elezi, A ; Braganca, A ; Zagdanski, AM ; Biard, L & al |
Efficacy of a deep learning-based software for chest X-ray analysis in an emergency department. |
Diagn Interv Imaging |
2025 |
|
|
| 10.1186/s13613-025-01439-x |
40.180.676 |
Serre, J ; Mulier, G ; Boud””hors, C ; Lemerle, M ; Abdel-Nabey, M ; Orvain, C & al |
Impact of early versus conventional kidney replacement therapy initiation in tumor lysis syndrome: a target trial emulation. |
Ann Intensive Care |
2025 |
15 |
49 |
| 10.1038/s44321-025-00203-9 |
40.148.586 |
Sam, I ; Benhamouda, N ; Biard, L ; Da Meda, L ; Desseaux, K ; Baroudjan, B & al |
Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma. |
EMBO Mol Med |
2025 |
17 |
909-922 |
| 10.1182/blood.2024027620 |
40.127.397 |
Corre, J ; Vincent, L ; Moreau, P ; Hebraud, B ; Hulin, C ; Béné, MC & al |
Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease results. |
Blood |
2025 |
146 |
679-692 |
| 10.1016/j.jbspin.2025.105889 |
40.096.884 |
Bardin, T ; Nguyen, QD ; Bousson, V ; Tran, K ; Dalbeth, N ; Tran, C & al |
Addition of allopurinol to traditional Vietnamese medicine shows major improvement of 100 gout patients in a single center one-year prospective study. |
Joint Bone Spine |
2025 |
92 |
105889 |
| 10.1016/j.semarthrit.2025.152660 |
39.978.288 |
Gérard, AL ; Vieira, M ; Cohen, A ; Hassanaly, O ; Lambert, J ; Saadoun, D |
Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals” Public Assistance. |
Semin Arthritis Rheum |
2025 |
71 |
152660 |
| 10.1007/s00701-024-06409-z |
39.891.775 |
Nataf, F ; Scher, N ; Bollet, M ; Mulier, G ; Birladeanu, A ; Sopanda, L & al |
Improving methodology of radiosurgery for posterior fossa cavernomas: higher volume, lower dose. |
Acta Neurochir (Wien) |
2025 |
167 |
29 |
| 10.1182/blood.2024026230 |
39.841.461 |
Perrot, A ; Touzeau, C ; Lambert, J ; Hulin, C ; Caillot, D ; Karlin, L & al |
Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial. |
Blood |
2025 |
146 |
52-61 |
| 10.1002/hem3.70081 |
39.840.381 |
Marouf, A ; Chaubard, S ; Liévin, R ; Michot, JM ; Molinari, N ; Rossignol, J & al |
Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA. |
Hemasphere |
2025 |
9 |
e70081 |
| 10.1016/j.jaut.2025.103360 |
39.826.312 |
Espitia, O ; Bruneval, P ; Liozon, E ; Pouchot, J ; de Boysson, H ; Gaudric, J & al |
Histological pattern of non-infectious thoracic aortitis impacts mortality. |
J Autoimmun |
2025 |
151 |
103360 |
| 10.1016/j.jeph.2024.202805 |
39.826.203 |
Mulier, G ; Ghosn, W ; Martin, D ; Hebbache, Z ; Coudin, E ; Fresson, J & al |
Neonatal mortality in 2001-2017 in France: A cause-specific and spatiotemporal analysis. |
J Epidemiol Popul Health |
2025 |
73 |
202805 |
| 10.1016/S2665-9913(24)00298-4 |
39.706.212 |
Farge, D ; Biard, L ; Weil, B ; Girault, V ; Lansiaux, P ; Munia, I & al |
Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study. |
Lancet Rheumatol |
2025 |
7 |
e261-e273 |
| 10.1007/s00277-024-06076-1 |
39.499.299 |
Tomowiak, C ; Poulain, S ; Nudel, M ; Feugier, P ; Herbaux, C ; Mahé, B & al |
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström”s macroglobulinemia. |
Ann Hematol |
2025 |
104 |
685-690 |
| 10.1016/j.ejso.2024.108746 |
39.424.524 |
Chatelet, F ; Chevret, S ; Fakhry, N ; Even, C ; Malard, O ; de Monès, E & al |
Impact of facial nerve resection in parotid cancer abutting the facial nerve without preoperative paralysis: A multicentric propensity score-based analysis. |
Eur J Surg Oncol |
2025 |
51 |
108746 |
| 10.1093/rheumatology/keae331 |
38.970.381 |
Bletry, D ; Meyblum, L ; Desseaux, K ; Vautier, M ; Chiche, L ; Le Joncour, A & al |
Impact of conventional and biological disease-modifying anti-rheumatic drugs on arterial lesions in Takayasu arteritis. |
Rheumatology (Oxford) |
2025 |
64 |
675-681 |
| 10.1080/10543406.2023.2236216 |
37.496.233 |
Andrillon, A ; Biard, L ; Lee, SM |
Incorporating patient-reported outcomes in dose-finding clinical trials with continuous patient enrollment. |
J Biopharm Stat |
2025 |
35 |
839-850 |
